In a study comparing 6.4 million COVID-19 vaccine recipients with 4.6 million demographically similar unvaccinated persons, recipients of the Pfizer, Moderna or Janssen vaccines had lower non-COVID-19 mortality risk than did the unvaccinated comparison groups, the Centers for Disease Control and Prevention  this week.

鈥淭here is no increased risk for mortality among COVID-19 vaccine recipients,鈥 the authors said. 鈥淭his finding reinforces the safety profile of currently approved COVID-19 vaccines in the United States.鈥

According to another  released this week by the CDC, adults under age 50 accounted for a larger proportion of patients hospitalized with COVID-19 after the delta variant became predominant, which the authors said was driven by the larger number of unvaccinated hospitalized patients in this age group.
 

Related News Articles

Headline
The Food and Drug Administration July 15 announced a recall by Sandoz on certain lots of cefazolin, due to the lots being mislabeled as penicillin G potassium鈥
Headline
 The Food and Drug Administration July 10 approved Moderna鈥檚 Spikevax COVID-19 vaccine for children under 12 with at least one underlying condition that鈥
Headline
The Occupational Safety and Health Administration June 30 released a proposed rule to remove what remains of its emergency temporary standard for occupational鈥
Headline
Department of Health and Human Services Secretary Robert F. Kennedy Jr. May 27 announced in a post on X that the Centers for Disease Control and Prevention鈥
Headline
Leaders of the Food and Drug Administration May 20 announced new guidelines for administering the COVID-19 vaccine in a paper published by the New England鈥
Headline
A study published April 8 by the Public Library of Science鈥檚 Journal of Global Public Health found that driving while infected with COVID-19 raises the risk of鈥